• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性罗阿丝虫病:一例暴露后六年确诊的罗阿罗阿丝虫感染病例。

Delayed-Onset Loiasis: A Case of Loa loa Infection Diagnosed Six Years Post-exposure.

作者信息

Root Halle N, Bueno Diana, Bathurst Nicholas, Wieting Michael

机构信息

Medical School, Lincoln Memorial University, DeBusk College of Osteopathic Medicine, Knoxville, USA.

Medical School, Lincoln Memorial University, DeBusk College of Osteopathic Medicine, Harrogate, USA.

出版信息

Cureus. 2025 Jun 16;17(6):e86135. doi: 10.7759/cureus.86135. eCollection 2025 Jun.

DOI:10.7759/cureus.86135
PMID:40672032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12266084/
Abstract

Loiasis, caused by , is a filarial infection endemic to Central and West Africa, increasingly recognized in non-endemic regions due to global migration and travel. Diagnosis in non-endemic regions can be challenging due to delayed symptom onset. We report a case of a 40-year-old woman presenting with ocular discomfort and a migrating subcutaneous parasite six years after residing in Gabon. Laboratory evaluation revealed eosinophilia and microfilariae on peripheral blood smear, confirming loiasis. Initial treatment with albendazole led to inflammatory symptoms, highlighting the risk of post-treatment reactions. This case underscores the importance of recognizing loiasis in patients with remote travel history, the need for careful microfilarial burden assessment, and multidisciplinary management to optimize treatment outcomes.

摘要

罗阿丝虫病由[具体病原体未给出]引起,是中非和西非特有的一种丝虫感染,由于全球移民和旅行,在非流行地区越来越多地被认识到。由于症状出现延迟,非流行地区的诊断可能具有挑战性。我们报告一例40岁女性病例,该患者在加蓬居住6年后出现眼部不适和皮下移行寄生虫。实验室检查显示外周血涂片嗜酸性粒细胞增多和微丝蚴,确诊为罗阿丝虫病。阿苯达唑初始治疗导致炎症症状,突出了治疗后反应的风险。该病例强调了在有远程旅行史的患者中识别罗阿丝虫病的重要性,需要仔细评估微丝蚴负荷,以及多学科管理以优化治疗结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/12266084/bde1c066e3da/cureus-0017-00000086135-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/12266084/88dc3cbcf02a/cureus-0017-00000086135-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/12266084/bde1c066e3da/cureus-0017-00000086135-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/12266084/88dc3cbcf02a/cureus-0017-00000086135-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/12266084/bde1c066e3da/cureus-0017-00000086135-i02.jpg

相似文献

1
Delayed-Onset Loiasis: A Case of Loa loa Infection Diagnosed Six Years Post-exposure.迟发性罗阿丝虫病:一例暴露后六年确诊的罗阿罗阿丝虫感染病例。
Cureus. 2025 Jun 16;17(6):e86135. doi: 10.7759/cureus.86135. eCollection 2025 Jun.
2
A cross-sectional investigation of the ophthalmological impact of loiasis in Cameroon, Central Africa.中非喀麦隆盘尾丝虫病眼部影响的横断面调查。
PLoS Negl Trop Dis. 2025 Jun 26;19(6):e0013216. doi: 10.1371/journal.pntd.0013216. eCollection 2025 Jun.
3
Efficacy and safety of albendazole 400 mg for 30 days compared to single dose of ivermectin in adult patients with low Loa loa microfilaremia: A non-inferiority randomized controlled trial.与单剂量伊维菌素相比,阿苯达唑400毫克治疗30天对低盘尾丝虫微丝蚴血症成年患者的疗效和安全性:一项非劣效性随机对照试验。
PLoS Negl Trop Dis. 2025 Jun 20;19(6):e0012383. doi: 10.1371/journal.pntd.0012383. eCollection 2025 Jun.
4
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.强力霉素加伊维菌素与单用伊维菌素治疗盘尾丝虫病患者的疗效比较
Cochrane Database Syst Rev. 2016 Jan 15;2016(1):CD011146. doi: 10.1002/14651858.CD011146.pub2.
5
Plasma Proteomics Reveals Distinct Signatures in Occult and Microfilaremic Loa loa Infections.
J Infect Dis. 2025 Sep 15;232(3):e383-e392. doi: 10.1093/infdis/jiaf344.
6
Ivermectin for onchocercal eye disease (river blindness).用于治疗盘尾丝虫性眼病(河盲症)的伊维菌素。
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD002219. doi: 10.1002/14651858.CD002219.pub2.
7
Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial.左旋咪唑3天和5天疗程治疗罗阿丝虫病的安全性和有效性:一项随机、安慰剂对照、双盲临床试验
Nat Commun. 2025 Jul 4;16(1):6191. doi: 10.1038/s41467-025-61479-6.
8
Clinical and epidemiological features of imported loiasis in Beijing: a report from patients returned from Africa.北京输入性罗阿丝虫病的临床和流行病学特征:来自非洲返回人员的报告。
BMC Infect Dis. 2024 Jul 20;24(1):714. doi: 10.1186/s12879-024-09620-6.
9
Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement.关于长新冠患者评估与治疗的多学科协作指南:一份概要声明
PM R. 2025 Apr 22. doi: 10.1002/pmrj.13397.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting.慢性罗阿罗阿线虫感染及其在流行地区治疗中的嗜酸性粒细胞、嗜碱性粒细胞和髓源性抑制细胞。
PLoS Negl Trop Dis. 2024 May 21;18(5):e0012203. doi: 10.1371/journal.pntd.0012203. eCollection 2024 May.
2
The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis.非洲眼线虫:对罗阿丝虫病流行病学、临床疾病及治疗的当前认识
Lancet Infect Dis. 2024 Mar;24(3):e165-e178. doi: 10.1016/S1473-3099(23)00438-3. Epub 2023 Oct 16.
3
Diagnostic Identification and Differentiation of Microfilariae.
微丝蚴的诊断鉴定和鉴别。
J Clin Microbiol. 2019 Sep 24;57(10). doi: 10.1128/JCM.00706-19. Print 2019 Oct.
4
Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.罗阿罗阿丝虫病传播媒介蚋属:研究、分布、生态学及对消灭淋巴丝虫病和盘尾丝虫病影响的展望。
Parasit Vectors. 2017 Apr 5;10(1):172. doi: 10.1186/s13071-017-2103-y.
5
Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas.嗜酸性粒细胞相关过程是导致罗阿丝虫病在临时居民和罗阿丝虫流行地区原住民临床表现差异的原因。
Clin Infect Dis. 2015 Jan 1;60(1):55-63. doi: 10.1093/cid/ciu723. Epub 2014 Sep 18.
6
Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years.输入性罗阿丝虫病:3例病例及过去25年非流行国家报告病例的综述
Int J Infect Dis. 2012 Sep;16(9):e649-62. doi: 10.1016/j.ijid.2012.05.1023. Epub 2012 Jul 10.
7
The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA).非洲罗阿罗阿丝虫的地理分布:大规模实施罗阿丝虫快速评估程序(RAPLOA)的结果。
PLoS Negl Trop Dis. 2011 Jun;5(6):e1210. doi: 10.1371/journal.pntd.0001210. Epub 2011 Jun 28.
8
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.喀麦隆大规模伊维菌素治疗盘尾丝虫病相关罗阿丝虫严重不良事件的临床表现、流行病学及结局
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S4. doi: 10.1186/1475-2883-2-S1-S4.
9
Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.伊维菌素治疗盘尾丝虫病后出现三例可能的罗阿丝虫脑病病例。
Am J Trop Med Hyg. 1998 Apr;58(4):461-9. doi: 10.4269/ajtmh.1998.58.461.